Dr. Mukund Chorghade is President of Chorghade Enterprises and Chief Scientific Officer, THINQ Pharma/THINQ Discovery, AGN Biofuels and Empiriko. He is also an adjunct research professor at Northeastern University and has appointments at Harvard and MIT. He provides synthetic chemistry and development expertise to pharmaceutical and biopharmaceutical companies. He also provides consultations on collaborations with academic, government and industrial laboratories. He advises technology based companies on process re-engineering and project management of technology transfer; establishes strategic partnerships and conducts cGLP/cGMP compliance training and implementation in chemical laboratories. He oversees projects in medicinal chemistry, chemical route selection, manufacturing and formulation of bulk actives to finished dosage forms.
Dr. Chorghade earned his B.Sc. and M.Sc. degrees from the University of Poona, and a Ph.D. in organic chemistry at Georgetown University. He completed postdoctoral appointments at the University of Virginia and Harvard University, visiting scientist appointments at University of British Columbia, College de France/Universite’ Louis Pasteur, Cambridge and Caltech and directed research groups at Dow Chemicals, Abbott Laboratories, CytoMed and Genzyme. A recipient of three “Scientist of the Year Awards”, he is an elected Fellow of the ACS, AAAS and RSC and has been a featured speaker in several national and international symposia. He is active in ACS, AAAS, RSC, was NESACS and Brazosport Section Chair and serves on numerous professional Scientific Advisory Boards and Committees.
